Tsudome, Riku, et al. “Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction”. Cardiology Research, vol. 16, no. 6, Dec. 2025, pp. 489-98, https://doi.org/10.14740/cr2109.